Abstract
The physiological proliferation of T lymphocytes (T cells) requires interaction between the humoral growth factor, interleukin 2 (IL-2) and its cell-surface receptor1,2. Studies of IL-2 binding to the IL-2 receptor (IL-2R) on T cells have revealed that there are two distinct species of IL-2R, one with high and one with low affinity3. Isolation and characterization of cDNA for the human IL-2R4–6 made it possible to deduce the complete primary sequence (251 residues) of the receptor protein. However, expression of IL-2R alone is not sufficient for either growth signal transduction or high-affinity site formation7,8: another lymphocyte-specific molecule called conver-ter seems to be required for the biological activity of IL-2R9–13. We found that the converter did not form a stable complex with IL-2R unless the receptor bound the ligand (the 'affinity conversion' model)12,13. To discover which are the functionally important parts of the human IL-2R we have constructed artificial mutant cDNAs encoding the receptor. The mutant receptors produced from them had deletions or substitutions in the cytoplasmic region (13 residues), the transmembrane region (19 residues) or the carboxy-terminal portion of the extracellular region (219 residues). All were active in growth signal transduction, efficient internalization and high-affinity site formation in two mouse T-cell lines, suggesting that the extracellular region of IL-2R and the converter may be responsible for growth signal transduction.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
1. Morgan, D. A., Ruscetti, F. W. & Gallo, R. C. Science 193, 1007–1008 (1976). 2. Smith, K. A. Immunol. Rev. 51, 337–353 (1980). 3. Robb, R. J., Greene, W. C. & Rusk, C. M. / exp. Med. 160, 1126–1146 (1984). 4. Nikaido, T. et al. Nature 311, 631–635 (1984). 5. Leonard, W. J. et al. Nature 311, 626–631 (1984). 6. Cosman, D. et al. Nature 312, 768–771 (1984). 7. Sabe, H. et al. Molec. Biol. Med. 2, 379–396 (1984). 8. Greene, W. C. et al. J. exp. Med. 162, 363–368 (1985). 9. Kondo, S. et al. Nature 320, 75–77 (1986). 10. Hatakeyama, M. et al. Nature 318, 467–469 (1985). 11. Robb, R. J. Proc. natn. Acad. Sci. U.S.A. 83, 3992–3996 (1986). 12. Shimizu, A., Kondo, S., Sabe, H., Ishida, N. & Honjo, T. Immunol. Rev. 92,103–120 (1986). 13. Kondo, S., Shimizu, A., Saito, Y., Kinoshita, M. & Honjo, T. Proc. natn. Acad. Sci. U.S.A. 83, 9026–9029 (1986). 14. Shackelford, D. A. & Trowbridge, I. S. J. biol. Chem. 261, 8334–8341 (1986). 15. Gallis, B. et al. J. biol. Chem. 261, 5075–5080 (1986). 16. Credig, R., Lowenthal, J. W., Nabholz, M. & MacDonald, H. R. Nature 314,98–100 (1985). 17. Uchiyama, T., Broder, S. & Waldmann, T. A. /. Immun. 126, 1393–1397 (1981). 18. Malek, T. R., Robb, R. J. & Shevach, E. M. Proc. natn. Acad. Sci. U.S.A. 80,5694–5698 (1983). 19. Fujii. M. et al. J. Immun. 137, 1552–1556 (1986). 20. Ullrich, A. et al. Nature 309, 418–425 (1984). 21. Zoller, M. J. & Smith, M. Meth. Enzym. 100, 468–500 (1983). 22. Capko, C. L., Roberts, B. E. & Mulligan, R. C. Cell 37, 1053–1062 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kondo, S., Kinoshita, M., Shimizu, A. et al. Expression and functional characterization of artificial mutants of interleukin-2 receptor. Nature 327, 64–67 (1987). https://doi.org/10.1038/327064a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/327064a0
This article is cited by
-
T cell costimulation, checkpoint inhibitors and anti-tumor therapy
Journal of Biosciences (2020)
-
Expression of functional interleukin-2 receptors in human light chain/Tac ransgenic mice
Nature (1988)
-
Expression of functional human interleukin‐2 receptors in murine interleukin‐3‐dependent cells
Immunology & Cell Biology (1988)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
